Morgan Stanley upgrades Gilead on HIV treatment growth By Investing.com
Investing.com -- Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:) to "chubby" from "equal weight," elevating its worth goal to $113 from ...
Tag: HIV
Investing.com -- Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:) to "chubby" from "equal weight," elevating its worth goal to $113 from ...